Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
clinical trials
life sciences
national blog main
allergan
artificial intelligence
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
bluebird bio
crispr
cynthia collins
drugs
duchenne muscular dystrophy
dyne therapeutics
editas medicine
facioscapulohumeral muscular dystrophy
gene editing
gene therapy
joshua brumm
kaleido biosciences
katrine bosley
leber congenital amaurosis
muscular dystrophy
myotonic dystrophy type 1
national top stories
new york blog main
rare disease drugs
romesh subramanian
san diego blog main
san francisco blog main
science
susanna high
tech
vertex pharmaceuticals
What
experimental
4
×
humans
4
×
medicine
early
trial
according
ago
allergan
allows
antibody
appears
biotechs
blessing
bosley
break
breakthrough
can’t
ceo
check
chimpanzee
clinical
cold
common
considering
consisting
crispr
cusp
data
demonstrates
depart
department
developed
different
diseases
doses
drug
dyne
ebola
editas
editing
Language
unset
Current search:
experimental
×
humans
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@thenextweb.com
4 years ago
Breakthrough research demonstrates AI can predict a psychotic break
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@theverge.com
9 years ago
An experimental Ebola vaccine looks promising in a human trial
